BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 25012265)

  • 1. Optimal prophylactic method of venous thromboembolism for gastrectomy in Korean patients: an interim analysis of prospective randomized trial.
    Song KY; Yoo HM; Kim EY; Kim JI; Yim HW; Jeon HM; Park CH
    Ann Surg Oncol; 2014 Dec; 21(13):4232-8. PubMed ID: 25012265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Venous Thromboembolism Incidence and Prophylaxis Use After Gastrectomy Among Korean Patients With Gastric Adenocarcinoma: The PROTECTOR Randomized Clinical Trial.
    Jung YJ; Seo HS; Park CH; Jeon HM; Kim JI; Yim HW; Song KY
    JAMA Surg; 2018 Oct; 153(10):939-946. PubMed ID: 30027281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of short-term (3 days) enoxaparin in preventing venous thromboembolism after gastric cancer surgery: A single-center, prospective cohort study.
    Kuroda S; Kikuchi S; Kakiuchi Y; Watanabe M; Kuwada K; Tsumura T; Nishizaki M; Kagawa S; Hinotsu S; Fujiwara T
    Int J Surg; 2021 May; 89():105946. PubMed ID: 33892160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized controlled trial of enoxaparin versus intermittent pneumatic compression for venous thromboembolism prevention in Japanese surgical patients with gynecologic malignancy.
    Nagata C; Tanabe H; Takakura S; Narui C; Saito M; Yanaihara N; Okamoto A
    J Obstet Gynaecol Res; 2015 Sep; 41(9):1440-8. PubMed ID: 26111609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intermittent pneumatic compression versus additional prophylaxis with enoxaparin for prevention of venous thromboembolism after laparoscopic surgery for gastric and colorectal malignancies: multicentre randomized clinical trial.
    Kamachi H; Homma S; Kawamura H; Yoshida T; Ohno Y; Ichikawa N; Yokota R; Funakoshi T; Maeda Y; Takahashi N; Amano T; Taketomi A
    BJS Open; 2020 Oct; 4(5):804-810. PubMed ID: 32700415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Phase II Clinical Trial of the Efficacy and Safety of Short-term (3 days) Enoxaparin for the Prevention of Venous Thromboembolism after Gastric Cancer Surgery.
    Kuroda S; Kikuchi S; Nishizaki M; Kagawa S; Hinotsu S; Fujiwara T
    Acta Med Okayama; 2016 Oct; 70(5):401-404. PubMed ID: 27777435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preventing Venous Thromboembolism with Use of Intermittent Pneumatic Compression after Total Hip Arthroplasty in Korean Patients.
    Jo WL; Lee YK; Ha YC; Lee KM; Kang BJ; Koo KH
    J Korean Med Sci; 2016 Aug; 31(8):1319-23. PubMed ID: 27478345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intermittent Pneumatic Compression for the Prevention of Venous Thromboembolism after Total Hip Arthroplasty.
    Kwak HS; Cho JH; Kim JT; Yoo JJ; Kim HJ
    Clin Orthop Surg; 2017 Mar; 9(1):37-42. PubMed ID: 28261425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Four years of an aggressive prophylaxis and screening protocol for venous thromboembolism in a large trauma population.
    Adams RC; Hamrick M; Berenguer C; Senkowski C; Ochsner MG
    J Trauma; 2008 Aug; 65(2):300-6; discussion 306-8. PubMed ID: 18695464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of enoxaparin for preventing venous thromboembolic events after laparoscopic colorectal cancer surgery: a randomized-controlled trial (YCOG 1404).
    Nakagawa K; Watanabe J; Ota M; Suwa Y; Suzuki S; Suwa H; Momiyama M; Ishibe A; Saigusa Y; Yamanaka T; Kunisaki C; Endo I
    Surg Today; 2020 Jan; 50(1):68-75. PubMed ID: 31385041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and Effectiveness of Enoxaparin as Venous Thromboembolism Prophylaxis after Gastric Cancer Surgery in Japanese Patients.
    Yanagita T; Kusanagi H
    Am Surg; 2016 Dec; 82(12):1232-1237. PubMed ID: 28234190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective study on the efficacies of fondaparinux and enoxaparin in preventing venous thromboembolism after hip fracture surgery.
    Sasaki S; Miyakoshi N; Matsuura H; Saito H; Nakanishi T; Kudo Y; Fujiya T; Shimada Y
    J Orthop Sci; 2011 Jan; 16(1):64-70. PubMed ID: 21293896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A prospective study on the incidence of postoperative venous thromboembolism in Korean gastric cancer patients: an inquiry into the application of Western guidelines to Asian cancer patients.
    Kim JW; Chun EJ; Choi SI; Park DJ; Kim HH; Bang SM; Kim MJ; Lee JH; Lee MS; Lee JO; Kim YJ; Kim JH; Lee JS; Lee KW
    PLoS One; 2013; 8(4):e61968. PubMed ID: 23613988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is extended thromboprophylaxis necessary in elective colorectal cancer surgery?
    Chandra R; Melino G; Thomas M; Lawrence MJ; Hunter RA; Moore J
    ANZ J Surg; 2013 Dec; 83(12):968-72. PubMed ID: 23802729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extended-duration venous thromboembolism prophylaxis in acutely ill medical patients with recently reduced mobility: a randomized trial.
    Hull RD; Schellong SM; Tapson VF; Monreal M; Samama MM; Nicol P; Vicaut E; Turpie AG; Yusen RD;
    Ann Intern Med; 2010 Jul; 153(1):8-18. PubMed ID: 20621900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thromboprophylaxis in gynecologic cancer surgery: Is extended prophylaxis with low molecular weight heparin justified?
    Marques de Marino P; Rial Horcajo R; Garcia Grandal T; Sanchez Hervas L; Serrano Hernando FJ; Herraiz Martinez MA; Coronado Martin PJ
    Eur J Obstet Gynecol Reprod Biol; 2018 Nov; 230():90-95. PubMed ID: 30245443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and efficacy of fondaparinux for prophylaxis of venous thromboembolism after colorectal cancer resection: a propensity score matched analysis.
    Yamaoka Y; Ikeda M; Ikenaga M; Haraguchi N; Miyake M; Sekimoto M
    Dig Surg; 2015; 32(3):190-5. PubMed ID: 25871913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence of venous thromboembolism after robotic-assisted hysterectomy in obese patients with endometrial cancer: do we need extended prophylaxis?
    Carbajal-Mamani SL; Dideban B; Schweer D; Balavage KT; Chuang L; Wang Y; Wang S; Lee JH; Amaro B; Cardenas-Goicoechea J
    J Robot Surg; 2021 Jun; 15(3):343-348. PubMed ID: 32592139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The EFFORT trial: Preoperative enoxaparin versus postoperative fondaparinux for thromboprophylaxis in bariatric surgical patients: a randomized double-blind pilot trial.
    Steele KE; Canner J; Prokopowicz G; Verde F; Beselman A; Wyse R; Chen J; Streiff M; Magnuson T; Lidor A; Schweitzer M
    Surg Obes Relat Dis; 2015; 11(3):672-83. PubMed ID: 25620436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The efficacy of fondaparinux for the prophylaxis of venous thromboembolism after resection for colorectal cancer.
    Tsutsumi S; Yajima R; Tabe Y; Takaaki T; Fujii F; Morita H; Kigure W; Kato T; Yamauchi H; Suto T; Asao T; Kuwano H
    Hepatogastroenterology; 2012; 59(120):2477-9. PubMed ID: 23169180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.